Effect of tumor-infiltrating lymphocyte subsets on prognosis and susceptibility to interferon therapy in patients with renal cell carcinoma

Urologia Internationalis

Volumn 69, Issue 1, 2002, Pages 51-56

  Igarashi, Tatsuo ^a   Takahashi, Hidenori ^b   Tobe, Toyofusa ^a   Suzuki, Hiroyoshi ^a   Mizoguchi, Kenichi ^a   Nakatsu, Hiro Omi ^b   Ito, Haruo ^a  

^a CHIBA UNIVERSITY   (Japan)

^b ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

CD4; CD8; Interferon; Prognosis; Renal cell carcinoma; Tumor infiltrating lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERFERON; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CELL ACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LONG TERM CARE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; FEMALE; HUMAN; INTERFERONS; KIDNEY NEOPLASMS; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGE; PROGNOSIS; HUMANS; MIDDLE AGED;

EID: 0035996245     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064361     Document Type: Article

References (21)

1. 2 in combination with 5-FU
2. Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma?
3. T-cell subpopulation in patients with metastatic renal cell carcinoma treated by recombinant interleukin-2, recombinant interferon-alpha, 5-fluorouracil, and vinblastine
4. Prognostic factors of peripheral blood lymphocyte subsets in patients with renal cell carcinoma
5. Increased LAK and T cell activation in responding renal cell carcinoma patients after low dose cyclophosphamide, IL-2 and alpha-IFN
6. The relationships among tumor-infiltrating lymphocytes, histopathologic findings, and long-term clinical follow-up in renal cell carcinoma
7. Changes on distribution of CD4+/CD45RA- and CD8+/CD11- cells in tumor-infiltrating lymphocytes of renal cell carcinoma associated with tumor progression
8. Functional analysis of mononuclear cells infiltrating into tumors: Lysis of autologous human tumor cells by cultured infiltrating lymphocytes
9. Prognostic significance of tumor-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: A multiparameter flow cytometry study
10. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating lymphocytes in human renal cell carcinoma
11. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells
12. Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria
13. Tumor-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment
14. Human renal cell carcinoma antigen-specific CTLs: Antigen-driven selection and long-term persistence in vivo
15. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy
16. Early sCD8 plasma levels during subcutaneous rIL-2 therapy in patients with renal cell carcinoma correlate with response
17. Regulation of human T lymphocyte chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-gamma, IL-4, IL-10, and IL-13
18. Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration
19. Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes
20. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma